Singapore researchers develop point-of-care COVID-19 diagnostic system

By LabPulse.com staff writers

June 29, 2020 -- Researchers from the National University of Singapore (NUS) have developed a portable COVID-19 microfluidics-based polymerase chain reaction (PCR) test system called Epidax.

The system allows patients to get tested for the disease at the point of care and receive results in about an hour, according to the university's Institute for Health Innovation and Technology (iHealthtech). It is about the size of a toaster, and processes nasal samples right after they are collected, bypassing the step of RNA extraction.

The NUS team has filed a patent for Epidax and is talking to a medical technology firm about bringing it to market, the university said.

World market outlook: COVID-19 testing evolves rapidly, lessons sink in
Worldwide, COVID-19 testing volume was on target to grow 25%-30% from May to June, reports Kalorama Information analyst Justin Saeks.
The case for a national COVID-19 testing strategy: A Q&A with Dr. Gary Procop
Dr. Gary Procop, chair of the American Society for Clinical Pathology's commission on science, technology, and policy, makes the case for a national testing...
Virality COVID-19 rapid antibody test gets emergency clearance
Virality Diagnostics has received an emergency use authorization from the U.S. Food and Drug Administration for a rapid COVID-19 antibody test.
Gencurix SARS-CoV-2 diagnostic gets emergency authorization
Gencurix has announced that it has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its GenePro SARS-CoV-2...
Terahertz spectroscopy opens options in COVID-19 screening
While terahertz spectroscopy has found some niche uses in research it has yet to find its "killer app." It's possible that it may find one in detecting...

Copyright © 2020 LabPulse.com

Last Updated ls 6/29/2020 2:29:55 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email